Page 6 - Phase Labs News Today

StockNews.com started coverage on shares of ProPhase Labs (NASDAQ:PRPH – Get Rating) in a research note issued to investors on Monday. The brokerage set a “sell” rating on the stock. PRPH has been the topic of several other research reports. TheStreet raised shares of ProPhase Labs from a “d+” rating to a “c-” rating in […]

Brokerages expect ProPhase Labs, Inc. (NASDAQ:PRPH – Get Rating) to report $24.31 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for ProPhase Labs’ earnings. The highest sales estimate is $32.05 million and the lowest is $16.57 million. ProPhase Labs posted sales of $15.27 million in the […]

StockNews.com started coverage on shares of ProPhase Labs (NASDAQ:PRPH – Get Rating) in a research note published on Sunday. The brokerage issued a sell rating on the stock. PRPH has been the subject of several other research reports. TheStreet raised shares of ProPhase Labs from a d+ rating to a c- rating in a research […]

ProPhase Labs (NASDAQ:PRPH – Get Rating) will be announcing its earnings results before the market opens on Wednesday, March 30th. Analysts expect the company to announce earnings of $0.36 per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link. NASDAQ PRPH opened at […]

StockNews.com began coverage on shares of ProPhase Labs (NASDAQ:PRPH – Get Rating) in a note issued to investors on Saturday. The firm set a “sell” rating on the stock. A number of other analysts have also weighed in on the stock. HC Wainwright increased their price objective on shares of ProPhase Labs from $12.00 to […]

Analysts expect ProPhase Labs, Inc. (NASDAQ:PRPH – Get Rating) to post sales of $22.92 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for ProPhase Labs’ earnings, with estimates ranging from $15.84 million to $30.00 million. The firm is expected to issue its next quarterly earnings results on Monday, […]

StockNews.com started coverage on shares of ProPhase Labs (NASDAQ:PRPH – Get Rating) in a research report released on Friday. The brokerage issued a sell rating on the stock. Other research analysts have also issued reports about the stock. Zacks Investment Research raised shares of ProPhase Labs from a hold rating to a buy rating and […]

ProPhase Labs to Present at LD Micro Invitational XI Virtual Conference CEO , 2021 GARDEN CITY, NY, May 28, 2021 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced that CEO Ted Karkus will present at the LD Micro Invitational XI virtual conference taking place June 8-10, 2021. Ted Karkus, Chief Executive Officer, is scheduled to host a virtual presentation during the event as follows: 2021 LD Micro Invitational XI Date...

12 Health Care Stocks Moving In Thursdays After-Market Session Gainers Bionano Genomics (NASDAQ:BNGO) stock rose 9.29% to $4.82 during Thursday’s after-market session. Today’s trading volume for this security ended up closing at 2.3 million shares, which is 8.85 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $1.3 billion. The company’s, Q1 earnings came out today. Applied DNA Sciences (NASDAQ:APDN) stock increased by 8.93% to $6.4...

Company Description ProPhase Labs Inc is a manufacturer and distributor of homeopathic and health products. It is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter consumer healthcare products, dietary supplements and other remedies in the United States. Its products include TK supplements such as Legendz XL, Triple Edge XL, a daily energy and stamina booster, and Super ProstaFlow to support prostate and urinary health. The companys operatin...